Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 9 results:
Author Title [ Type] Year Filters: Author is Eleutherakis-Papaiakovou, Evangelos [Clear All Filters]
Bortezomib-based triplets are associated with a high probability of dialysis independence and rapid renal recovery in newly diagnosed myeloma patients with severe renal failure or those requiring dialysis..
Am J Hematol. 91(5), 499-502.
(2016). Cardiac and renal complications of carfilzomib in patients with multiple myeloma..
Blood Adv. 1(7), 449-454.
(2017). Coexistence of leishmaniasis and multiple myeloma in the era of monoclonal antibody (anti-CD38 or anti-SLAMF7) containing triplets: one shared story of two exceptional cases..
Leuk Lymphoma. 59(4), 983-987.
(2018).
(2018). Evaluation of minimal residual disease using next-generation flow cytometry in patients with AL amyloidosis..
Blood Cancer J. 8(5), 46.
(2018). Evaluation of the Revised International Staging System in an independent cohort of unselected patients with multiple myeloma..
Haematologica. 102(3), 593-599.
(2017). Growth differentiation factor-15 is a new biomarker for survival and renal outcomes in light chain amyloidosis..
Blood. 131(14), 1568-1575.
(2018). Hematologic and renal improvement of monoclonal immunoglobulin deposition disease after treatment with bortezomib-based regimens..
Leuk Lymphoma. 58(8), 1832-1839.
(2017). Renal outcomes in patients with AL amyloidosis: Prognostic factors, renal response and the impact of therapy..
Am J Hematol. 92(7), 632-639.
(2017).